great news
just for clarification; do we know what the "required dosis" is for the actual treatment of patients?
Meaning, what happens if at a certain dosage we start seeing some major side effects? Would the previous safely tolerated dosage be the max. for the trials in sick patients?
Ann: Positive Safety Data from Second Cohort of PI Clinical Trial, page-22
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.005(1.08%) |
Mkt cap ! $108.9M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.0¢ | 45.5¢ | $112.0K | 245.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111416 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 2511 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| RCE (ASX) Chart |